Canadian physicians are being advised to reduce their prescribing of opioid medication to patients with chronic non-cancer pain in a new guideline for clinical care that focuses on harm reduction.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
Canadian physicians are being advised to reduce their prescribing of opioid medication to patients with chronic non-cancer pain in a new guideline for clinical care that focuses on harm reduction.
The U.S. Food and Drug Administration approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.
Ipsen announced that it has completed its previously announced acquisition of a portfolio of five consumer healthcare products from Sanofi.
[adsense:336x280:8701650588]
The Uttar Pradesh government has launched a vaccination campaign in six of its districts where by children receive free vaccines against pneumonia to combat the threat.
As the number of opioid-related deaths continues to rise across Canada, new federal legislation is aimed at reducing the number of deaths from overdoses.
The World Health Organization (WHO) is to launch a pilot project this year to evaluate inexpensive copies of costly drugs for biotechnology cancer to make these drugs more accessible in the poorest countries.
The US House of Representatives, controlled by the Republicans, passed a new version of the American Health Care Act to repeal and replace Obamacare, by a vote of 217 to 213. The Republican leaders of the house have blurred to gain sufficient support for the vote after adding a series of changes since an earlier version was taken from a vote in Parliament at the last minute of March.
Researchers have developed a custom algorithm that predicts the impact of certain foods on an individual's blood sugar, according to a new study published in PLOSComputational Biology.
Roche Diagnostics UK and Ireland launches the next generation of INR patient self-monitoring meter for patients on warfarin anticoagulant therapy. The new CoaguChek INRange meter allows patients to send their results to their clinic via an App on their phone using wireless connectivity.
Takeda Pharmaceutical Company Limited announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under Accelerated Approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. ALUNBRIG, which previously received Breakthrough Therapy Designation from the FDA, is a once-daily oral therapy that may be taken with or without food.